COMMUNIQUÉS West-GlobeNewswire

Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults
03/01/2019
Sets the Stage for Phase 3 Clinical Trial in 2019 Phase 2 clinical trial confirmed Phase 1/2 results, again demonstrating improved immune responses over Fluzone ® High-Dose End-of-Phase 2 meeting with the FDA expected [...]
MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System
03/01/2019
Limited Market Release Marks the First Internally Developed Therapeutic Product Added to the Company Portfolio IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform [...]
Amicus Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019
CRANBURY, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present a corporate overview at the 37 th Annual J.P [...]
Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease
03/01/2019
IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase 2 meeting with the [...]
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2018 Revenue and Initial Revenue Guidance for 2019
03/01/2019
Fourth-quarter 2018 revenue estimated to be approximately $9.5 million, an increase of 36% over the previous quarter Full-year 2018 revenue estimated to be approximately $22.5 million Flexion providing initial 2019 [...]
Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference
03/01/2019
WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 37 th Annual J.P [...]
Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE™ in San Francisco on Wednesday, January 9, 2019
03/01/2019
WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Quality improvement interventions improve efficacy of depression screening and follow-up
03/01/2019
Study appears in January 2019 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Depression is the leading cause of disability and often goes [...]
Canopy Rivers Engages Hybrid Financial for Investor Relations Services
03/01/2019
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) today announced that it has retained Hybrid Financial Ltd. (“ Hybrid ”), a marketing and retail [...]
OSE Immunotherapeutics to present at Biotech Showcase™ 2019 Conference
03/01/2019
During JP Morgan Healthcare Conference San Francisco, January 7-9, 2019 NANTES, France, Jan. 03, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE), today announced that Alexis Peyroles, [...]
Vistin Pharma ASA : Head of Energy Trading resigns
03/01/2019
Oslo, Norway, 3 January 2019 Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA, has decided to resign from his position to pursue other interests. As a result of the resignation of Torbjørn Kjus, the Board of [...]
UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
03/01/2019
MINNEAPOLIS, Jan. 03, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX-V:DMA) announced today that the U.S. Food and Drug Administration ("FDA") has accepted DiaMedica’s [...]
EHNAC Announces Finalized 2019 Accreditation Criteria Versions for All Accreditation Programs
03/01/2019
Incorporation of GDPR and New York State Cybersecurity Requirements are top updates to EHNAC accreditation program criteria FARMINGTON, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network [...]
Merit Medical Announces Appointment of Two New Directors
03/01/2019
SOUTH JORDAN, Utah, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Aptevo Therapeutics Collects $3.3 Million In Escrow Funds From Saol Therapeutics
03/01/2019
SEATTLE, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that it has collected $3.3 [...]
New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health
03/01/2019
IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance DUBLIN and CAMBRIDGE, Mass. - January 3, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, [...]
Cerner and CoverMyMeds Collaborate to Improve Prescription Price Transparency Within the EHR
03/01/2019
KANSAS CITY, Mo., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, has collaborated with CoverMyMeds to integrate patient-specific information into the electronic health record (EHR) [...]
Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy
03/01/2019
FREEHOLD, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies, announced today that the Company and its wholly owned subsidiary, Avactis [...]
Tizona Therapeutics Appoints Scott Clarke as Chief Executive Officer and Provides Update on Regulatory Milestone for its First-in-Class CD39 program in Cancer
03/01/2019
– New Leader to Guide Immunotherapy Biotech in its Next Phase of Growth – – FDA Accepts Tizona’s Investigational New Drug Application for TTX-030 – SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Tizona [...]

Pages